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ischemia by 4!% (!), the number of patients with 160 min of transient 
myocardial ischemia decreased by 10% and silent episodes by 5%. 
These data ail suggest a reduction in transient rnyocardial ischemia 
when heparin is added to aspirin. However, the differences did not 
reach statistical significance, probably because of the small sample stze. 
The authors speculate “that 260 patients would be needed to give 
sufficient power (85%) to show a 70% reduction in transient myocar- 
dial ischemia.” According to our calculations, to achieve a similar 
power to show a more realistic 25% reduction, a sample size of 910 
patients would have been needed. The authors’ own data actually do 
suggest a reduction of this magnitude. In our opinion, to expect a 70% 
reduction in ischemia incidence from the addition of heparin to 
aspirin, a treatment modality in itself of proved efficacy, was quite 
unrealistic. 
Too small a sample size in randomized controlled trials having 
negative results seems to be a common error according to data 
published recently in JAMA (3). Of 102 such studies, only 16% and 
36% had sufficient statistical power to detect a 25% or SO% relative 
difference, respectively. 
We believe that the authors’ data do not support their conclusion 
that heparin plus aspirin is no more effective than aspirin alone in 
unstable angina pectoris. In fact, their data suggest but do not prove 
that heparin plus aspirin is more effective. To draw defnitive conclu- 
sions, a substantially bigger study involving -1,000 patients would be 
required. 
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Bode ct al. raise a point that should be asked when any compartson of 
different treatment strategies indicates the treatment modalities in 
question to be the same with respect to predefined end points. They 
suggest that an inadequate sample size may be responsible for our 
finding that combination therapy with heparin and aspirin was no 
different than aspirin alone in reducing the incidence of transient 
myocardial ischaemia in patients with unstable angina. We welcome 
the opportunity to defend our sample size calculation. 
The sample size was based on the expected incidence of transient 
myocardial ischemia and the effects of heparin and aspirin on transient 
myocardial ischemia. We indicated in the report that the calculations 
were made on the basis of data from the study by Semeri et al. (1) in 
which the etfects of heparin, aspirin and alteplase on myocardial 
iachcmia were compared in patients with unstable angina. Using 
continuous ST segmen: Iloiter monitoring they compared the effects 
of these treatments on the frequency of angina, number of silent 
ischemic episodes, total number of ischemic episodes and total dura- 
tion of ischemia. Their results indicated that treatment with heparin 
reduced angina1 episodes by 94%, silent ischemjc episodes by 71% 
total ischemic episodes by 78% and tota: duration of ischemia by 81% 
In contrast, aspirin had no significant effect. The typical odds reduction 
for recurrence of angina with heparin versus other treatments was 66% 
(SD 6.4%) for days 0 to 3 (p < 0.0013). On the basis of these results 
we believe that our original power calculation was reasonable. We 
estimated that 260 patients would be required to show a 70% reduction 
in transient myocardial ischemia with heparin and aspirin compared 
with aspirin alone, assuming a 20% incidence of transient ischemia in 
patients treated with aspirin, giving a power of 85%. Because some 
patients will be included who, in retrospect, will be diagnosed as having 
myocardial infarction, we increased the sample size by a further 10%. 
We believe that it is reasonable to expect a 70% reduction in ischemia 
with the addition of heparin because that is supported by the data from 
Serneri et al. (1). 
As Bodo et al. indicate, the sample size of any trial should be 
carefully inspected, but they should not be drawn into making state- 
ments about treatment guidelines by interpreting data “trends” when 
statistical significance is not reached. For example, they make several 
comments about the data in Table 2 from which they suggest that 
combination therapy is superior to aspirin. To state that the number of 
patients with transient myocardial ischemia was 25% less in the 
combination group is misleading when the absolute numbers of 
patients were 31 in the aspirin group versus 27 in the heparin and 
aspirin group-a difference of 4 patients. Similariy, tile other variables 
mentioned by Bodo et al. are particularly influenced by one patient in 
the aspirin group who r‘lntributed 1,360 min of transient ischemia, 
which constituted >25Y~ of the total ischemia in that group. We high- 
lighted the point in the text of our article. Consequently, we believe that 
Bodo et al. have no basis for suggesting that our data indicate that heparin 
and aspirin therapy is superior to aspirin alone. 
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Early Repair of Tetralogy of Fallot and 
Ventricular Arrhythmia 
It has been suggcstsd that in patients with tetralogy of Faliot, 
occurrence of late ventricular arrhythmias and possibly sudden death 
would decrease if surgical correction is performed early in life. The 
work of Joffe et al. (I) has attempted to address this important issue. 
This study describes the iong-term follow-up results in 29 patients after 
repair of tctraiogy of Fallot. 
“Early” versus “late” repair of tetralogy of Fallot is not clearly 
defined in published reports. Nevertheless, “early” commonly implies 
complete repair at the time of, or even before, development of the 
need for palliative surgery. which usually occurs during the first year of 
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life (2). Patients in the Joffe et a!. study are younger overall than most 
of the previous studies on the subject of arrhythmias and tetralogy of 
Faiiot. However, most of these patients had undergone a previous 
palliative surgery (Bialock-Taussig shunt, 62%), and a!! of them were 
>l year old (mean age 4, range 1.2 to 7.7). The timing of operation, 
therefore, was not “early” for a significant number of these patients, 
and the question of potential long-term benefits of early repair remains 
unanswered. 
The authors have classified the patients into two groups: 21 with 
“uncomplicated” and 8 with “complex or repeated” operations. This 
approach is unprecedented in previous large studies; the available 
rates of prevalence and incidence of ventricular arrhythmia are 
obtained from patients with tetraiogy of Faiiot as a whole. Therefore, 
the low prevalence of ventricular arrhythmia in the JofFe et a!. 
“uncomplicated” group should not be compared with the higher :s!es 
in previous studies that include both the “uncomplicated” and “com- 
plex” patient groups. In the patients in the Joffe et al study, the overall 
prevalence of late ventricular arrhythmias was 28%. which should not 
be considered “rare.” 
The prevalence of significant ventricular arrhythmias after tetrai- 
ogy of Faiiot repair has been shown to increase with time, and most 
studies with long-term follow-up (up to 28 years) show a prevalence of 
-40% to 45% (3,4). The Joffe et a!. study also demonstrates the effect 
of passage of time on detection of ventricular arrhythmias: 14% of 
patients had significant ventricular arrhythmias at early compared with 
28% at late follow-up. However, the authors concluded that this 
difference was not significant because statistical comparison between 
the two groups yieided a p value >O.L A higher p value may have been 
due to small numbers and a low statistical poi*cr (type II error). It is 
likely, therefore, that the patients in the Joffe et a!. study had the same 
outcome as those with later repair. Furthermore, as the authors 
correctly point out, one of the still unsettled controversies regarding 
patients with tetraiogy of Failot is that ventricular arrhythmias may be 
a part of the natural history of the disease rather than secondary to 
operation. The long follow-up period (mean of 11.8 years) of the study, 
for which the authors should be commended, is still not long enough to 
rule ollt this possibility (the oldest patient evaluated was 21 years old). 
We, therefore, believe that it is premature to draw any valid conclu- 
sions from the study by Joffe et a!. regarding the potential benefits of 
“early” correction of tetraiogy of Failot in the prevention of late ventric- 
ular arrhythmias. 
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In Joffe et a! (I) we reported that late veniricuiar arrhy!hmias were less 
common after “early” repair of tetraiogy of Faiiot and when repair was 
“uncomplicated.” As Failah and Mehta point out. although our 
patients were younger than the series reported from the early surgical 
era: many still had a two-stage approach to their repair, with initial 
palliation. No long-term data have been published using smbuiatory 
electrocardiographic (ECG) monitoring in patients who underwent 
primary repair in infancy, but follow-up standard ECG data support 
our conclusion that early repair is likely to be beneficial (2). 
We classified our patients into “uncomplicated” and “complex” 
repair groups to illustrate the difference in prevalence and progression 
of ventricular arrhythmia in these two groups. The lower prevalence in 
the uncomplicated repairs is of interest in terms of etiology of late 
arrhythmia. We do not make direct comparisons between the preva- 
lence of arrhythmia in our prospective study and those of earlier 
retrospective reports. 
Failah and Mehta state that the prevalence of significant ventric- 
ular arrhythmia after tetraiogy of Faiiot repair increases with time. 
This has not been demonstrated because no prospective data have 
been reported. They fall into the trap of assuming that because 
ventricular arrhythmias are common in older patients with long 
follow-up after repair, they are increasing with time. The group that we 
studied was indeed small, and we cannot be confident that with 
increasing time there may not be an increase in arrhythmia in both 
groups during even longer follow-up. However, we emphasize that the 
references Faiiah and Mehta quote do not address the issue of 
increasing incidence of arrhythmia with follow-up, as they suggest 
(3,4). 
We and others (5,6) have previously published data that suggest 
that late veutricuiar arrhythmia may be part of the natural history of 
tetraiogy of Faiiot as a result of myocardiai damage in the uncorrected 
heart rather than secondary to operation. This natural history is 
interrupted by correction, and it is hard to see how longer postoper- 
ative follow-up would address this issue, as Fadah and Mehta imply. 
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